Cargando…
The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action
Current treatment approaches to manage neuropathic pain have a slow onset and their use is largely hampered by side-effects, thus there is a significant need for finding new medications. Tolperisone, a centrally acting muscle relaxant with a favorable side effect profile, has been reported to affect...
Autores principales: | Lakatos, Péter P., Karádi, Dávid Árpád, Galambos, Anna Rita, Essmat, Nariman, Király, Kornél, Laufer, Rudolf, Geda, Orsolya, Zádori, Zoltán S., Tábi, Tamás, Al-Khrasani, Mahmoud, Szökő, Éva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455595/ https://www.ncbi.nlm.nih.gov/pubmed/36076962 http://dx.doi.org/10.3390/ijms23179564 |
Ejemplares similares
-
Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats
por: Essmat, Nariman, et al.
Publicado: (2023) -
Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats
por: Karádi, David Á., et al.
Publicado: (2023) -
Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model
por: Mohammadzadeh, Amir, et al.
Publicado: (2021) -
Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain
por: Király, Kornél, et al.
Publicado: (2021) -
Recent Molecular Insights into Agonist-specific Binding to the Mu-Opioid Receptor
por: Zádor, Ferenc, et al.
Publicado: (2022)